Do you want to read an article? Please log in or register.
The role of adjuvant radiotherapy in pathologically lymph node positive prostate cancer
Genitourinary CancerRadio-Oncology
Related content
Gastrointestinal Cancer
The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts
Cancer.
Tran Cao HS, Zhang Q, Sada YH, Chai C, Curley SA, Massarweh NN
doi: 10.1002/cncr.30968.
Genitourinary CancerRadio-Oncology
Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer With Adverse Pathological Features
JAMA Oncol.
Hwang WL, Tendulkar RD, Niemierko A, Agrawal S, Stephans KL, Spratt DE, Hearn JW, Koontz BF, Lee WR, Michalski JM, Pisansky TM, Liauw SL, Abramowitz MC, Pollack A, Moghanaki D, Anscher MS, Den RB, Zietman AL, Stephenson AJ, Efstathiou JA
doi: 10.1001/jamaoncol.2017.5230.
RECOMMENDED
Genitourinary Cancer
Which Patients with Clinically Node-positive Prostate Cancer Should Be Considered for Radical Prostatectomy as Part of Multimodal Treatment? The Impact of Nodal Burden on Long-term Outcomes
doi: 10.1016/j.eururo.2018.10.042.
Genitourinary Cancer
Assessment of Postprostatectomy Radiotherapy as Adjuvant or Salvage Therapy in Patients With Prostate Cancer: A Systematic Review
JAMA Oncol.
Sachdev S, Carroll P, Sandler H, Nguyen PL, Wafford E, Auffenberg G, Schaeffer E, Roach M 3rd, Evans CP, Hussain M
doi: 10.1001/jamaoncol.2020.2832.
RECOMMENDED
Genitourinary Cancer
Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial
★ 3
Recommended by
Alexander Meisel, Faculty Member
Lancet Oncol.
Sargos P, Chabaud S, Latorzeff I, Magné N, Benyoucef A, Supiot S, Pasquier D, Abdiche MS, Gilliot O, Graff-Cailleaud P, Silva M, Bergerot P, Baumann P, Belkacemi Y, Azria D, Brihoum M, Soulié M, Richaud P
doi: 10.1016/S1470-2045(20)30454-X.Visit the original publication at ncbi.nlm.nih.gov
RECOMMENDED
Genitourinary Cancer
Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial
★ 3
Recommended by
Alexander Meisel, Faculty Member
Lancet Oncol
Sargos P, Chabaud S, Latorzeff I, Magné N, Benyoucef A, Supiot S, Pasquier D, Abdiche MS, Gilliot O, Graff-Cailleaud P, Silva M, Bergerot P, Baumann P, Belkacemi Y, Azria D, Brihoum M, Soulié M, Richaud P
doi: 10.1016/S1470-2045(20)30454-X
Breast CancerRadio-Oncology
Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial
Eur J Surg Oncol.
Sávolt Á, Péley G, Polgár C, Udvarhelyi N, Rubovszky G, Kovács E, Győrffy B, Kásler M, Mátrai Z
doi: 10.1016/
Skin Cancer
A model for predicting low probability of nonsentinel lymph node positivity in melanoma patients with a single positive sentinel lymph node
Bhutiani N, Egger ME, Stromberg AJ, Gershenwald JE, Ross MI, Philips P, Martin RCG 2nd, Scoggins CR, McMasters KM
doi: 10.1002/jso.25193.
Breast Cancer
Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial
Br J Cancer.
Ribi K, Luo W, Colleoni M, Karlsson P, Chirgwin J, Aebi S, Jerusalem G, Neven P, Di Lauro V, Gomez HL, Ruhstaller T, Abdi E, Biganzoli L, Müller B, Barbeaux A, Graas MP, Rabaglio M, Francis PA, Foukakis T, Pagani O, Graiff C, Vorobiof D, Maibach R, Di Leo A, Gelber RD, Goldhirsch A, Coates AS, Regan MM, Bernhard J; SOLE Investigators
doi: 10.1038/s41416-019-0435-4.